About this Event
6001 Forest Park Road, Dallas, TX 75235
Join the Harold C. Simmons Comprehensive Cancer Center on May 3 - 4, 2024, for the Wendy & Emery Reves International Breast Cancer Symposium.
Register here.
The Reves Symposium is a premier event at UT Southwestern whose objectives are to review the recent progress in breast cancer research and improvements in the clinical care of patients with breast cancer. The Reves Symposium provides information on the latest laboratory-based translational discoveries and new technologies, while exploring developments in treatment options, clinical trials, and population sciences. Attendees include breast cancer providers and nursing professionals, basic and translational scientists, physician-scientists, clinical trialists, laboratory-based postdoctoral and clinical fellows, graduate students, patient advocates, and interested individuals from industry and the community.
Chairs
Carlos L. Arteaga, M.D. | Director, SCCC
Deborah Farr, M.D.
Heather McArthur, M.D., M.P.H.
Keynote Speakers
Elizabeth Mittendorf, M.D., Ph.D., M.H.C.M.
Dana-Farber/Harvard Cancer Center
Joan Massague, Ph.D.
Sloan Kettering Institute
Day 1, May 3
7:15 – 8:25 a.m. REGISTRATION AND BREAKFAST
8:25 – 8:30 a.m. Carlos L. Arteaga, M.D. | Welcome Remarks
Session 1 (Genomics): 25 min talk + 5 min QA
8:30 – 9 a.m. Chuck Perou, Ph.D., UNC Lineberger Breast Cancer Research Program
9 – 9:30 a.m. Rinath Jeselsohn, M.D., Harvard Medical School/Dana-Farber Cancer Institute
9:30 – 10 a.m. Zoltan Szallasi, M.D., Boston Children's Hospital
10 – 10:20 a.m. BREAK
10:20 – 11 a.m. Elizabeth Mittendorf, M.D., Ph.D., MHCM, Dana-Farber/Harvard Cancer Center | Keynote Speaker
Session 2 (Local Therapy): 25 min talk + 5 min QA
11 – 11:30 am Shelley Hwang, M.D., Duke University
11:30 – Noon Silvia Formenti, M.D., Weill Cornell
Noon – 1:15 p.m. LUNCH
Session 3 (Endocrine Therapy/ER): 25 min talk + 5 min QA
1:15 – 1:45 p.m. Kevin Kalinsky, M.D., Emory University
1:45 – 2:15 p.m. Ann Partridge, M.D., M.P.H., Dana-Farber Cancer Institute
2:15 – 2:45 p.m. Steffi Oesterreich, Ph.D., University of Pittsburgh
2:45 – 3 p.m. BREAK
Session 4 (Pathology/Imaging/AI): 25 min talk + 5 min QA
3 – 3:30 p.m. Regina Barzilay, Ph.D., MIT
3:30 – 4 p.m. David Rimm, M.D., Ph.D., Yale University
4 – 4:30 p.m. Elizabeth Morris, M.D., UC Davis
Day 2, May 4
7:30 – 8 a.m. REGISTRATION AND BREAKFAST
Session 5 (Drug Development): 25 min talk + 5 min QA
8 – 8:30 a.m. David Cescon, M.D., Ph.D., Princess Margaret Cancer Centre
8:30 – 9 a.m. Komal Jhaveri, M.D., Memorial Sloan Kettering Cancer Center
9 - 9:30 a.m. Qing Zhang, Ph.D., Harold C. Simmons Comprehensive Cancer Center, UTSW
9:30 – 10:10 a.m. Keynote Speaker: Joan Massague, Ph.D., Sloan Kettering Institute (35 min talk + 5 min QA)
10:10–10:30 a.m. BREAK
Session 6 (Cell Cycle and CDK4/6 inhibitors): 25 min talk + 5 min QA
10:30 – 11 a.m. Piotr Sicinski, Ph.D., Harvard Medical School/Dana-Farber Cancer Institute
11 – 11:30 a.m. Angie DeMichele, M.D., University of Pennsylvania
11:30 – Noon Sarat Chandarlapaty, M.D., Ph.D., Memorial Sloan Kettering Cancer Center
Session 7 (Breast Cancer Immunology): 25 min talk + 5 min QA
12 – 12:30 p.m. Nora Disis, M.D., Fred Hutchinson Cancer Center
12:30 – 1 p.m. Heather McArthur, M.D., M.P.H., UT Southwestern Medical Center
1 –1:15 p.m. Carlos L. Arteaga, M.D. | Closing Remarks